Comparison of the bioavailability of aminophylline in a conventional base and in a continous-release base.

C. Boroda,R. Miller,S. T. Leslie,E. Nicol,I. Thomson

DOI: https://doi.org/10.1002/J.1552-4604.1973.TB00183.X

1973-10-01

Abstract:

What problem does this paper attempt to address?

MosaicHunter: Accurate Detection of Postzygotic Single-Nucleotide Mosaicism Through Next-Generation Sequencing of Unpaired, Trio, and Paired Samples

August Yue Huang,Zheng Zhang,Adam Yongxin Ye,Yanmei Dou,Linlin Yan,Xiaoxu Yang,Yuehua Zhang,Liping Wei

DOI: https://doi.org/10.1093/nar/gkx024

IF: 14.9

2017-01-01

Nucleic Acids Research

Abstract:Genomic mosaicism arising from postzygotic mutations has long been associated with cancer and more recently with non-cancer diseases. It has also been detected in healthy individuals including healthy parents of children affected with genetic disorders, highlighting its critical role in the origin of genetic mutations. However, most existing software for the genome-wide identification of single-nucleotide mosaicisms (SNMs) requires a paired control tissue obtained from the same individual which is often unavailable for non-cancer individuals and sometimes missing in cancer studies. Here, we present MosaicHunter (http://mosaichunter.cbi.pku.edu.cn), a bioinformatics tool that can identify SNMs in whole-genome and whole-exome sequencing data of unpaired samples without matched controls using Bayesian genotypers. We evaluate the accuracy of MosaicHunter on both simulated and real data and demonstrate that it has improved performance compared with other somatic mutation callers. We further demonstrate that incorporating sequencing data of the parents can be an effective approach to significantly improve the accuracy of detecting SNMs in an individual when a matched control sample is unavailable. Finally, MosaicHunter also has a paired mode that can take advantage of matched control samples when available, making it a useful tool for detecting SNMs in both non-cancer and cancer studies.
DeepMosaic: Control-independent mosaic single nucleotide variant detection using deep convolutional neural networks

Xiaoxu Yang,Xin Xu,Martin W. Breuss,Danny Antaki,Laurel L. Ball,Changuk Chung,Chen Li,Renee D. George,Yifan Wang,Taejeoing Bae,Alexej Abyzov,Liping Wei,Jonathan Sebat,NIMH Brain Somatic Mosaicism Network,Joseph G. Gleeson

DOI: https://doi.org/10.1101/2020.11.14.382473

2021-01-01

Abstract:Mosaic variants (MVs) reflect mutagenic processes during embryonic development[1][1] and environmental exposure[2][2], accumulate with aging, and underlie diseases such as cancer and autism[3][3]. The detection of MVs has been computationally challenging due to sparse representation in non-clonally expanded tissues. While heuristic filters and tools trained on clonally expanded MVs with high allelic fractions are proposed, they show relatively lower sensitivity and more false discoveries[4][4]–[9][5]. Here we present DeepMosaic, combining an image-based visualization module for single nucleotide MVs, and a convolutional neural networks-based classification module for control-independent MV detection. DeepMosaic achieved higher accuracy compared with existing methods on biological and simulated sequencing data, with a 96.34% (158/164) experimental validation rate. Of 932 mosaic variants detected by DeepMosaic in 16 whole genome sequenced samples, 21.89-58.58% (204/932-546/932) MVs were overlooked by other methods. Thus, DeepMosaic represents a highly accurate MV classifier that can be implemented as an alternative or complement to existing methods. ### Competing Interest Statement The authors have declared no competing interest. [1]: #ref-1 [2]: #ref-2 [3]: #ref-3 [4]: #ref-4 [5]: #ref-9
Control-independent mosaic single nucleotide variant detection with DeepMosaic

Xiaoxu Yang,Xin Xu,Martin W. Breuss,Danny Antaki,Laurel L. Ball,Changuk Chung,Jiawei Shen,Chen Li,Renee D. George,Yifan Wang,Taejeong Bae,Yuhe Cheng,Alexej Abyzov,Liping Wei,Ludmil B. Alexandrov,Jonathan L. Sebat,Joseph G. Gleeson,Dan Averbuj,Subhojit Roy,Eric Courchesne,August Y. Huang,Alissa D’Gama,Caroline Dias,Christopher A. Walsh,Javier Ganz,Michael Lodato,Michael Miller,Pengpeng Li,Rachel Rodin,Robert Hill,Sara Bizzotto,Sattar Khoshkhoo,Zinan Zhou,Alice Lee,Alison Barton,Alon Galor,Chong Chu,Craig Bohrson,Doga Gulhan,Eduardo Maury,Elaine Lim,Euncheon Lim,Giorgio Melloni,Isidro Cortes,Jake Lee,Joe Luquette,Lixing Yang,Maxwell Sherman,Michael Coulter,Minseok Kwon,Peter J. Park,Rebeca Borges-Monroy,Semin Lee,Sonia Kim,Soo Lee,Vinary Viswanadham,Yanmei Dou,Andrew J. Chess,Attila Jones,Chaggai Rosenbluh,Schahram Akbarian,Ben Langmead,Jeremy Thorpe,Sean Cho,Andrew Jaffe,Apua Paquola,Daniel Weinberger,Jennifer Erwin,Jooheon Shin,Michael McConnell,Richard Straub,Rujuta Narurkar,Yeongjun Jang,Cindy Molitor,Mette Peters,Fred H. Gage,Meiyan Wang,Patrick Reed,Sara Linker,Alexander Urban,Bo Zhou,Xiaowei Zhu,Aitor S. Amero,David Juan,Inna Povolotskaya,Irene Lobon,Manuel S. Moruno,Raquel G. Perez,Tomas Marques-Bonet,Eduardo Soriano,Gary Mathern,Diane Flasch,Trenton Frisbie,Huira Kopera,Jeffrey Kidd,John Moldovan,John V. Moran,Kenneth Kwan,Ryan Mills,Sarah Emery,Weichen Zhou,Xuefang Zhao,Aakrosh Ratan,Alexandre Jourdon,Flora M. Vaccarino,Liana Fasching,Nenad Sestan,Sirisha Pochareddy,Soraya Scuderi,

DOI: https://doi.org/10.1038/s41587-022-01559-w

IF: 46.9

2023-01-02

Nature Biotechnology

Abstract:Mosaic variants (MVs) reflect mutagenic processes during embryonic development and environmental exposure, accumulate with aging and underlie diseases such as cancer and autism. The detection of noncancer MVs has been computationally challenging due to the sparse representation of nonclonally expanded MVs. Here we present DeepMosaic, combining an image-based visualization module for single nucleotide MVs and a convolutional neural network-based classification module for control-independent MV detection. DeepMosaic was trained on 180,000 simulated or experimentally assessed MVs, and was benchmarked on 619,740 simulated MVs and 530 independent biologically tested MVs from 16 genomes and 181 exomes. DeepMosaic achieved higher accuracy compared with existing methods on biological data, with a sensitivity of 0.78, specificity of 0.83 and positive predictive value of 0.96 on noncancer whole-genome sequencing data, as well as doubling the validation rate over previous best-practice methods on noncancer whole-exome sequencing data (0.43 versus 0.18). DeepMosaic represents an accurate MV classifier for noncancer samples that can be implemented as an alternative or complement to existing methods.

biotechnology & applied microbiology
A robust benchmark for detecting low-frequency variants in the HG002 Genome In A Bottle NIST reference material.

Camille Daniels,Adetola Abdulkadir,Megan H. Cleveland,Jennifer H. McDaniel,David Jaspez,Luis Alberto Rubio-Rodriguez,Adrian Munoz-Barrera,Jose Miguel Lorenzo-Salazar,Carlos Flores,Byunggil Yoo,Sayed Mohammad Ebrahim Sahraeian,Yina Wang,Massimiliano Rossi,Arun Visvanath,Lisa Murray,Wei-Ting Chen,Severine Catreux,James Han,Rami Mehio,Gavin Parnaby,Andrew Carroll,Pi-Chuan Chang,Kishwar Shafin,Daniel E. Cook,Alexey Kolesnikov,Lucas Brambrink,Mohammed Faizal Eeman Mootor,Yash Patel,Takafumi N. Yamaguchi,Paul C. Boutros,Karolina Sienkiewicz,Jonathan Foox,Christopher E. Mason,Bryan Lajoie,Carlos A. Ruiz-Perez,Semyon Kruglyak,Justin M. Zook,Nathan D. Olson

DOI: https://doi.org/10.1101/2024.12.02.625685

2024-12-05

Abstract:Somatic mosaicism is an important cause of disease, but mosaic and somatic variants are often challenging to detect because they exist in only a fraction of cells. To address the need for benchmarking subclonal variants in normal cell populations, we developed a benchmark containing mosaic variants in the Genome in a Bottle Consortium (GIAB) HG002 reference material DNA from a large batch of a normal lymphoblastoid cell line. First, we used a somatic variant caller with high coverage (300x) Illumina whole genome sequencing data from the Ashkenazi Jewish trio to detect variants in HG002 not detected in at least 5% of cells from the combined parental data. These candidate mosaic variants were subsequently evaluated using >100x BGI, Element, and PacBio HiFi data. High confidence candidate SNVs with variant allele fractions above 5% were included in the HG002 draft mosaic variant benchmark, with 13/85 occurring in medically relevant gene regions. We also delineated a 2.45 Gbp subset of the previously defined germline autosomal benchmark regions for HG002 in which no additional mosaic variants >2% exist, enabling robust assessment of false positives. The variant allele fraction of some mosaic variants is different between batches of cells, so using data from the homogeneous batch of reference material DNA is critical for benchmarking these variants. External validation of this mosaic benchmark showed it can be used to reliably identify both false negatives and false positives for a variety of technologies and detection algorithms, demonstrating its utility for optimization and validation. By adding our characterization of mosaic variants in this widely-used cell line, we support extensive benchmarking efforts using it in simulation, spike-in, and mixture studies.

Bioinformatics
Comprehensive identification of somatic nucleotide variants in human brain tissue

Yifan Wang,Taejeong Bae,Jeremy Thorpe,Maxwell A. Sherman,Attila G. Jones,Sean Cho,Kenneth Daily,Yanmei Dou,Javier Ganz,Alon Galor,Irene Lobon,Reenal Pattni,Chaggai Rosenbluh,Simone Tomasi,Livia Tomasini,Xiaoxu Yang,Bo Zhou,Schahram Akbarian,Laurel L. Ball,Sara Bizzotto,Sarah B. Emery,Ryan Doan,Liana Fasching,Yeongjun Jang,David Juan,Esther Lizano,Lovelace J. Luquette,John B. Moldovan,Rujuta Narurkar,Matthew T. Oetjens,Rachel E. Rodin,Shobana Sekar,Joo Heon Shin,Eduardo Soriano,Richard E. Straub,Weichen Zhou,Andrew Chess,Joseph G. Gleeson,Tomas Marquès-Bonet,Peter J. Park,Mette A. Peters,Jonathan Pevsner,Christopher A. Walsh,Daniel R. Weinberger,Flora M. Vaccarino,John V. Moran,Alexander E. Urban,Jeffrey M. Kidd,Ryan E. Mills,Alexej Abyzov,

DOI: https://doi.org/10.1186/s13059-021-02285-3

IF: 17.906

2021-03-29

Genome Biology

Abstract:Abstract Background Post-zygotic mutations incurred during DNA replication, DNA repair, and other cellular processes lead to somatic mosaicism. Somatic mosaicism is an established cause of various diseases, including cancers. However, detecting mosaic variants in DNA from non-cancerous somatic tissues poses significant challenges, particularly if the variants only are present in a small fraction of cells. Results Here, the Brain Somatic Mosaicism Network conducts a coordinated, multi-institutional study to examine the ability of existing methods to detect simulated somatic single-nucleotide variants (SNVs) in DNA mixing experiments, generate multiple replicates of whole-genome sequencing data from the dorsolateral prefrontal cortex, other brain regions, dura mater, and dural fibroblasts of a single neurotypical individual, devise strategies to discover somatic SNVs, and apply various approaches to validate somatic SNVs. These efforts lead to the identification of 43 bona fide somatic SNVs that range in variant allele fractions from ~ 0.005 to ~ 0.28. Guided by these results, we devise best practices for calling mosaic SNVs from 250× whole-genome sequencing data in the accessible portion of the human genome that achieve 90% specificity and sensitivity. Finally, we demonstrate that analysis of multiple bulk DNA samples from a single individual allows the reconstruction of early developmental cell lineage trees. Conclusions This study provides a unified set of best practices to detect somatic SNVs in non-cancerous tissues. The data and methods are freely available to the scientific community and should serve as a guide to assess the contributions of somatic SNVs to neuropsychiatric diseases.

genetics & heredity,biotechnology & applied microbiology
Detection of Mosaic Absence of Heterozygosity (AOH) Using Low-Pass Whole Genome Sequencing in Prenatal Diagnosis: A Preliminary Report

Yan Lü,Yulin Jiang,Xiya Zhou,Na Hao,Chenlu Xu,Ruidong Guo,Jiazhen Chang,Mengmeng Li,Hanzhe Zhang,Jing Zhou,Wei (Victor) Zhang,Qingwei Qi

DOI: https://doi.org/10.3390/diagnostics13182895

IF: 3.6

2023-09-10

Diagnostics

Abstract:Objective: Mosaicism is a common biological phenomenon in organisms and has been reported in many types of chromosome abnormalities, including the absence of heterozygosity (AOH). Due to the detection limitations of the sequencing approach, mosaic AOH events are rarely assessed in clinical cases. Herein, we report the performance of mosaic AOH identification using a low-pass (5~8-fold) WGS method (termed 'CMA-seq', an abbreviation for 'Chromosome Analysis by Sequencing') in fetal genetic diagnosis. Methods: Thirty AOH-negative, eleven constitutional AOH, and three mosaic AOH samples were collected as training data sets to develop the algorithm and evaluate the suitable thresholds for distinguishing mosaic AOH. Twenty-four new chromosomal aberrant cases, along with sixteen constitutional AOH samples, which were previously ascertained via the SNP-array-based method, were used as a validation data set to measure the performance in terms of sensitivity and specificity of this algorithm. Results: A new statistic, 'D-value', was implemented to identify and distinguish constitutional and mosaic AOH events. The reporting thresholds for constitutional and mosaic AOH were also established. In the validation set consisting of 24 new cases, seven constitutional AOH cases and 1 mosaic AOH case were successfully identified, indicating that the results were consistent with those of the SNP-array-based method. The results of all sixteen constitutional AOH validation samples also met the threshold requirements. Conclusions: In this study, we developed a new bioinformatic algorithm to accurately distinguish mosaic AOH from constitutional AOH by low-pass WGS. However, due to the small sample size of the training data set, the algorithm proposed in this manuscript still needs further refinements.

medicine, general & internal
Detecting Somatic Mutations Without Matched Normal Samples Using Long Reads

Jared T. Simpson

DOI: https://doi.org/10.1101/2024.02.26.582089

2024-02-29

Abstract:DNA sequencing of tumours to identify somatic mutations has become a critical tool to guide the type of treatment given to cancer patients. The gold standard for mutation calling is comparing sequencing data from the tumour to a matched normal sample to avoid mis-classifying inherited SNPs as mutations. This procedure works extremely well, but in certain situations only a tumour sample is available. While approaches have been developed to find mutations without a matched normal, they have limited accuracy or require specific types of input data (e.g. ultra-deep sequencing). Here we explore the application of single molecule long read sequencing to calling somatic mutations without matched normal samples. We develop a simple theoretical framework to show how haplotype phasing is an important source of information for determining whether a variant is a somatic mutation. We then use simulations to assess the range of experimental parameters (tumour purity, sequencing depth) where this approach is effective. These ideas are developed into a prototype somatic mutation caller, smrest, and its use is demonstrated on two highly mutated cancer cell lines. Finally, we argue that this approach has potential to measure clinically important biomarkers that are based on the genome-wide distribution of mutations: tumour mutation burden and mutation signatures.

Bioinformatics
Genome-wide detection of somatic mosaicism at short tandem repeats

Aarushi Sehgal,Helyaneh Ziaei-Jam,Andrew Shen,Melissa Gymrek

DOI: https://doi.org/10.1093/bioinformatics/btae485

IF: 5.8

2024-07-30

Bioinformatics

Abstract:Abstract Motivation Somatic mosaicism has been implicated in several developmental disorders, cancers, and other diseases. Short tandem repeats (STRs) consist of repeated sequences of 1-6bp and comprise more than 1 million loci in the human genome. Somatic mosaicism at STRs is known to play a key role in the pathogenicity of loci implicated in repeat expansion disorders and is highly prevalent in cancers exhibiting microsatellite instability. While a variety of tools have been developed to genotype germline variation at STRs, a method for systematically identifying mosaic STRs is lacking. Results We introduce prancSTR, a novel method for detecting mosaic STRs from individual high-throughput sequencing datasets. prancSTR is designed to detect loci characterized by a single high-frequency mosaic allele, but can also detect loci with multiple mosaic alleles. Unlike many existing mosaicism detection methods for other variant types, prancSTR does not require a matched control sample as input. We show that prancSTR accurately identifies mosaic STRs in simulated data, demonstrate its feasibility by identifying candidate mosaic STRs in Illumina whole genome sequencing (WGS) data derived from lymphoblastoid cell lines for individuals sequenced by the 1000 Genomes Project, and evaluate the use of prancSTR on Element and PacBio data. In addition to prancSTR, we present simTR, a novel simulation framework which simulates raw sequencing reads with realistic error profiles at STRs. Availability prancSTR and simTR are freely available at https://github.com/gymrek-lab/trtools. Documentation Detailed documentation is available at https://trtools.readthedocs.io/ Supplementary information Supplementary data are available at Bioinformatics online.

biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
Mitosomatic: a Tool for Accurate Identification of Mitochondrial DNA Somatic Mutations Without Paired Controls

Wenjie Guo,Yang Liu,Liping Su,Shanshan Guo,Fanfan Xie,Xiaoying Ji,Kaixiang Zhou,Xu Guo,Xiwen Gu,Jinliang Xing

DOI: https://doi.org/10.1002/1878-0261.13335

2022-01-01

Molecular Oncology

Abstract:Mitochondrial DNA (mtDNA) somatic mutations play important roles in the initiation and progression of cancer. Although next-generation sequencing (NGS) of paired tumor and control samples has become a common practice to identify tumor-specific mtDNA mutations, the unique nature of mtDNA and NGS-associated sequencing bias could cause false-positive/-negative somatic mutation calling. Additionally, there are clinical scenarios where matched control tissues are unavailable for comparison. Therefore, a novel approach for accurately identifying somatic mtDNA variants is greatly needed, particularly in the absence of matched controls. In this study, the ground truth mtDNA variants orthogonally validated by triple-paired tumor, adjacent nontumor, and blood samples were used to develop mitoSomatic, a random forest-based machine learning tool. We demonstrated that mitoSomatic achieved area under the curve (AUC) values over 0.99 for identifying somatic mtDNA variants without paired control in three tumor types. In addition, mitoSomatic was also applicable in nontumor tissues such as adjacent nontumor and blood samples, suggesting the flexibility of mitoSomatic's classification capability. Furthermore, analysis of triple-paired samples identified a small group of variants with uncertain somatic/germline origin, whereas application of mitoSomatic significantly facilitated the prediction of their possible source. Finally, a control-free evaluation of the public pan-cancer NGS dataset with mitoSomatic revealed a substantial number of variants that were probably misclassified by conventional tumor-control comparison, further emphasizing the usefulness of mitoSomatic in application. Taken together, our study demonstrates that mitoSomatic is valuable for accurately identifying somatic mtDNA variants in mtDNA NGS data without paired controls, applicable for both tumor and nontumor tissues.
Resolving the chromatin impact of mosaic variants with targeted Fiber-seq

Stephanie C. Bohaczuk,Zachary J. Amador,Chang Li,Benjamin J. Mallory,Elliott G Swanson,Jane Ranchalis,Mitchell R. Vollger,Katherine M. Munson,Tom Walsh,Morgan O. Hamm,Yizi Mao,Andre Lieber,Andrew B. Stergachis

DOI: https://doi.org/10.1101/2024.07.09.602608

2024-07-13

Abstract:Accurately quantifying the functional consequences of non-coding mosaic variants requires the pairing of DNA sequence with both accessible and closed chromatin architectures along individual DNA molecules—a pairing that cannot be achieved using traditional fragmentation-based chromatin assays. We demonstrate that targeted single-molecule chromatin fiber sequencing (Fiber-seq) achieves this, permitting single-molecule, long-read genomic and epigenomic profiling across targeted >100 kilobase loci with ~10-fold enrichment over untargeted sequencing. Targeted Fiber-seq reveals that pathogenic expansions of the CTG repeat that underlie Myotonic Dystrophy 1 are characterized by somatic instability and disruption of multiple nearby regulatory elements, both of which are repeat length-dependent. Furthermore, we reveal that therapeutic adenine base editing of the segmentally duplicated γ-globin ( ) promoters in primary human hematopoietic cells induced towards an erythroblast lineage increases the accessibility of the promoter as well as neighboring regulatory elements. Overall, we find that these non-protein coding mosaic variants can have complex impacts on chromatin architectures, including extending beyond the regulatory element harboring the variant.

Genomics
Postzygotic Single-Nucleotide Mosaicisms in Whole-Genome Sequences of Clinically Unremarkable Individuals.

August Y Huang,Xiaojing Xu,Adam Y Ye,Qixi Wu,Linlin Yan,Boxun Zhao,Xiaoxu Yang,Yao He,Sheng Wang,Zheng Zhang,Bowen Gu,Han-Qing Zhao,Meng Wang,Hua Gao,Ge Gao,Zhichao Zhang,Xiaoling Yang,Xiru Wu,Yuehua Zhang,Liping Wei

DOI: https://doi.org/10.1038/cr.2014.131

2014-01-01

Abstract:Postzygotic single-nucleotide mutations (pSNMs) have been studied in cancer and a few other overgrowth human disorders at whole-genome scale and found to play critical roles. However, in clinically unremarkable individuals, pSNMs have never been identified at whole-genome scale largely due to technical difficulties and lack of matched control tissue samples, and thus the genome-wide characteristics of pSNMs remain unknown. We developed a new Bayesian-based mosaic genotyper and a series of effective error filters, using which we were able to identify 17 SNM sites from ∼80× whole-genome sequencing of peripheral blood DNAs from three clinically unremarkable adults. The pSNMs were thoroughly validated using pyrosequencing, Sanger sequencing of individual cloned fragments, and multiplex ligation-dependent probe amplification. The mutant allele fraction ranged from 5%-31%. We found that C→T and C→A were the predominant types of postzygotic mutations, similar to the somatic mutation profile in tumor tissues. Simulation data showed that the overall mutation rate was an order of magnitude lower than that in cancer. We detected varied allele fractions of the pSNMs among multiple samples obtained from the same individuals, including blood, saliva, hair follicle, buccal mucosa, urine, and semen samples, indicating that pSNMs could affect multiple sources of somatic cells as well as germ cells. Two of the adults have children who were diagnosed with Dravet syndrome. We identified two non-synonymous pSNMs in SCN1A, a causal gene for Dravet syndrome, from these two unrelated adults and found that the mutant alleles were transmitted to their children, highlighting the clinical importance of detecting pSNMs in genetic counseling.
mosaicMPI: a framework for modular data integration across cohorts and -omics modalities

Theodore B Verhey,Heewon Seo,Aaron Gillmor,Varsha Thoppey-Manoharan,David Schriemer,Sorana Morrissy

DOI: https://doi.org/10.1093/nar/gkae442

IF: 14.9

2024-06-01

Nucleic Acids Research

Abstract:Advances in molecular profiling have facilitated generation of large multi-modal datasets that can potentially reveal critical axes of biological variation underlying complex diseases. Distilling biological meaning, however, requires computational strategies that can perform mosaic integration across diverse cohorts and datatypes. Here, we present mosaicMPI, a framework for discovery of low to high-resolution molecular programs representing both cell types and states, and integration within and across datasets into a network representing biological themes. Using existing datasets in glioblastoma, we demonstrate that this approach robustly integrates single cell and bulk programs across multiple platforms. Clinical and molecular annotations from cohorts are statistically propagated onto this network of programs, yielding a richly characterized landscape of biological themes. This enables deep understanding of individual tumor samples, systematic exploration of relationships between modalities, and generation of a reference map onto which new datasets can rapidly be mapped. mosaicMPI is available at https://github.com/MorrissyLab/mosaicMPI.

biochemistry & molecular biology
Robust identification of extrachromosomal DNA and genetic variants using multiple genetic abnormality sequencing (MGA-Seq)

Da Lin,Yanyan Zou,Jinyue Wang,Qin Xiao,Fei Lin,Ningyuan Zhang,Zhaowei Teng,Shiyi Li,Yongchang Wei,Fuling Zhou,Rong Yin,Siheng Zhang,Chengchao Wu,Jing Zhang,Sheng Hu,Shuang Dong,Xiaoyu Li,Shengwei Ye,Haixiang Sun,Gang Cao

DOI: https://doi.org/10.1101/2022.11.18.517160

IF: 17.906

2022-01-01

Genome Biology

Abstract:Genomic abnormalities, including structural variation (SV), copy number variation (CNV), single-nucleotide polymorphism (SNP), homogenously staining regions (HSR) and extrachromosomal DNA (ecDNA), are strongly associated with cancer, rare diseases and infertility. A robust technology to simultaneously detect these genomic abnormalities is highly desired for clinical diagnosis and basic research. In this study, we developed a simple and cost-effective method – multiple genetic abnormality sequencing (MGA-Seq) – to simultaneously detect SNPs, CNVs, SVs, ecDNA and HSRs in a single tube. This method has been successfully applied in both cancer cell lines and clinical tumour samples and revealed that focal amplification in tumour tissue is substantially heterogeneous. Notably, we delineated the architecture of focal amplification and the ecDNA network by MGA-Seq, which facilitated the exploration of the regulation of gene expression in ecDNA. This method could be extensively applied for diagnosis and may greatly facilitate the investigation of the genomic mechanism for genetic diseases. ### Competing Interest Statement The authors have declared no competing interest.
High efficiency error suppression for accurate detection of low-frequency variants

Ting Ting Wang,Sagi Abelson,Jinfeng Zou,Tiantian Li,Zhen Zhao,John E Dick,Liran I Shlush,Trevor J Pugh,Scott V Bratman

DOI: https://doi.org/10.1093/nar/gkz474

IF: 14.9

2019-05-25

Nucleic Acids Research

Abstract:Abstract Detection of cancer-associated somatic mutations has broad applications for oncology and precision medicine. However, this becomes challenging when cancer-derived DNA is in low abundance, such as in impure tissue specimens or in circulating cell-free DNA. Next-generation sequencing (NGS) is particularly prone to technical artefacts that can limit the accuracy for calling low-allele-frequency mutations. State-of-the-art methods to improve detection of low-frequency mutations often employ unique molecular identifiers (UMIs) for error suppression; however, these methods are highly inefficient as they depend on redundant sequencing to assemble consensus sequences. Here, we present a novel strategy to enhance the efficiency of UMI-based error suppression by retaining single reads (singletons) that can participate in consensus assembly. This ‘Singleton Correction’ methodology outperformed other UMI-based strategies in efficiency, leading to greater sensitivity with high specificity in a cell line dilution series. Significant benefits were seen with Singleton Correction at sequencing depths ≤16 000×. We validated the utility and generalizability of this approach in a cohort of >300 individuals whose peripheral blood DNA was subjected to hybrid capture sequencing at ∼5000× depth. Singleton Correction can be incorporated into existing UMI-based error suppression workflows to boost mutation detection accuracy, thus improving the cost-effectiveness and clinical impact of NGS.

biochemistry & molecular biology
Detection of mosaic and population-level structural variants with Sniffles2

Moritz Smolka,Luis F. Paulin,Christopher M. Grochowski,Dominic W. Horner,Medhat Mahmoud,Sairam Behera,Ester Kalef-Ezra,Mira Gandhi,Karl Hong,Davut Pehlivan,Sonja W. Scholz,Claudia M. B. Carvalho,Christos Proukakis,Fritz J. Sedlazeck

DOI: https://doi.org/10.1038/s41587-023-02024-y

IF: 46.9

2024-01-02

Nature Biotechnology

Abstract:Abstract Calling structural variations (SVs) is technically challenging, but using long reads remains the most accurate way to identify complex genomic alterations. Here we present Sniffles2, which improves over current methods by implementing a repeat aware clustering coupled with a fast consensus sequence and coverage-adaptive filtering. Sniffles2 is 11.8 times faster and 29% more accurate than state-of-the-art SV callers across different coverages (5–50×), sequencing technologies (ONT and HiFi) and SV types. Furthermore, Sniffles2 solves the problem of family-level to population-level SV calling to produce fully genotyped VCF files. Across 11 probands, we accurately identified causative SVs around MECP2 , including highly complex alleles with three overlapping SVs. Sniffles2 also enables the detection of mosaic SVs in bulk long-read data. As a result, we identified multiple mosaic SVs in brain tissue from a patient with multiple system atrophy. The identified SV showed a remarkable diversity within the cingulate cortex, impacting both genes involved in neuron function and repetitive elements.

biotechnology & applied microbiology
On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients

Carlo Sala Frigerio,Pierre Lau,Claire Troakes,Vincent Deramecourt,Patrick Gele,Peter Van Loo,Thierry Voet,Bart De Strooper

DOI: https://doi.org/10.1016/j.jalz.2015.02.007

Abstract:Introduction: The cause of sporadic Alzheimer's disease (AD) remains unclear. Given the growing evidence that protein aggregates can spread in a "prion-like" fashion, we reasoned that a small population of brain cells producing such "prion-like" particles due to a postzygotic acquired mutation would be sufficient to trigger the disease. Deep DNA sequencing technology should in principle allow the detection of such mosaics. Methods: To detect the somatic mutations of genes causing AD present in a small number of cells, we developed a targeted deep sequencing approach to scrutinize the genomic loci of APP, PSEN1, and PSEN2 genes in DNA extracted from the entorhinal cortex, one of the brain regions showing the earliest signs of AD pathology. We also included the analysis of the MAPT gene because mutations may promote tangle formation. We validated candidate mutations with an independent targeted ultradeep amplicon sequencing technique. Results: We demonstrate that our approach can detect single-nucleotide mosaic variants with a 1% allele frequency and copy number mosaic variants present in as few as 10% of cells. We screened 72 AD and 58 control brain samples and identified three mosaic variants with low allelic frequency (∼1%): two novel MAPT variants in sporadic AD patients and a known PSEN2 variant in a Braak II control subject. Moreover, we detected both novel and known pathogenic nonmosaic heterozygous variants in PSEN1 and PSEN2 in this cohort of sporadic AD patients. Discussion: Our results show that mosaic mutations with low allelic frequencies in AD-relevant genes can be detected in brain-derived DNA, but larger samples need to be investigated before a more definitive conclusion with regard to the pathogenicity of such mosaics can be made.
Image-based DNA Sequencing Encoding for Detecting Low-Mosaicism Somatic Mobile Element Insertions

Miaomiao Tan,Zhinan Lin,Zhuofu Chen,Junseok Park,Ziting He,Haonan Zhou,Eunjung Alice Lee,Zhipeng Gao,Xiaowei Zhu

DOI: https://doi.org/10.1101/2024.11.07.619809

2024-11-08

Abstract:Active LINE-1 (L1), Alu, and SVA mobile elements in the human genome are capable of retrotransposition, resulting in novel mobile element insertions (MEIs) in both germline and somatic tissues. Detecting MEIs through DNA sequencing relies on supporting reads overlapping MEI junctions; however, artifacts from DNA amplification, sequencing, and alignment errors produce numerous false positives. Systematic detection of somatic MEIs, particularly those with low mosaicism, remains a significant challenge. Previous methods had required a high number of supporting reads which limits the detection sensitivity, or human inspections that are susceptible to biases. Here, we developed RetroNet, an algorithm that encodes MEI-supporting sequencing reads into images, and employs a deep neural network to identify somatic MEIs with as few as two reads. Trained on extensive and diverse datasets and benchmarked across various conditions, RetroNet surpasses previous methods and eliminates the need for extensive manual examinations. When applied to bulk whole genome sequencing of a cancer cell line, RetroNet achieved an average precision of 0.885 and recall of 0.845 for detecting somatic L1 insertions, including four true mutations with only two supporting reads. RetroNet is applicable to the rapidly generated short-read sequencing data and has the potential to provide further insights into the functional and pathological implications of somatic retrotranspositions.

Genomics
MosaicBase: A Knowledgebase of Postzygotic Mosaic Variants in Noncancer Diseases and Asymptomatic Human Individuals

Xiaoxu Yang,Changhong Yang,Xianing Zheng,Luoxing Xiong,Yutian Tao,Meng Wang,Adam Yongxin Ye,Qixi Wu,Yanmei Dou,Junyu Luo,Liping Wei,August Yue Huang

DOI: https://doi.org/10.1101/2020.03.04.976803

2020-01-01

Abstract:Mosaic variants resulting from postzygotic mutations are prevalent in the human genome and play important roles in human diseases. However, except for cancer-related variant collections, there are no collections of mosaic variants in noncancer diseases and asymptomatic individuals. Here, we present MosaicBase (<http://mosaicbase.cbi.pku.edu.cn/> or <http://49.4.21.8:8000/>), a comprehensive database that includes 6,698 mosaic variants related to 269 noncancer diseases and 27,991 mosaic variants identified in 422 asymptomatic individuals. The genomic and phenotypic information for each variant was manually extracted and curated from 383 publications. MosaicBase supports the query of variants with Online Mendelian Inheritance in Man (OMIM) entries, genomic coordinates, gene symbols, or Entrez IDs. We also provide an integrated genome browser for users to easily access mosaic variants and their related annotations within any genomic region. By analyzing the variants collected in MosaicBase, we found that mosaic variants that directly contribute to disease phenotype showed features distinct from those of variants in individuals with a mild or no phenotype in terms of their genomic distribution, mutation signatures, and fraction of mutant cells. MosaicBase will not only assist clinicians in genetic counseling and diagnosis but also provide a useful resource to understand the genomic baseline of postzygotic mutations in the general human population.
Abstract 4849: Mosaic chromosomal alterations in a prospective cohort of Mexican Americans for cancer risk and genetic insights

Jessica Valdebenito,Justin Wong,Dahwei Chang,Henry Gomez,Kevin T Nead,Yasminka Jakubek,Paul Scheet

DOI: https://doi.org/10.1158/1538-7445.am2024-4849

IF: 11.2

2024-03-24

Cancer Research

Abstract:Introduction: In this study, we aim to explore mosaic chromosomal alterations (mCA) and their implications in cancer risk among Mexican Americans (MA) - an expanding yet historically underrepresented ethnic minority in the U.S. In addition, we propose to develop a novel method that identifies high mutant cell fraction (MCF) copy-neutral Loss of heterozygosity (cn-LOH). At sufficiently high MCF, these will look like runs of homozygosity (ROH) and may be missed by current mCA detection techniques that rely on identified germline heterozygote genotypes. Our preliminary findings revealed frequent and widespread homozygosity across the genome, predominantly in short regions (<10 Mb), although some exceeded 100 Mb. Our objective is to advance mCA detection techniques, differentiating cn-LOH from ROH, to deepen our understanding of mCA. Methods: We analyzed SNP array data from blood and saliva samples of 1657 individuals, focusing on cancer and chronic disease risk ages, from the Mano a Mano Mexican American Cohort Study. We applied hapLOH and MoChA, both haplotype-based methods, to detect mCA. To identify high-MCF cn-LOH, we first scanned for observed ROH using PLINK. Separately, we develop a statistical framework through simulations to differentiate high-MCF cn-LOH from ROH. We considered multiple methods; initially, we built a statistical framework using a hypothesis-testing approach (H0: ROH; H1: cn-LOH), where we compared the "B allele" frequency information within observed ROH. To split this information and obtain our groups, we used population genetic principles. Secondly, we classified our events, calculating the likelihood ratio of our statistical hypotheses. Finally, we explored a haplotype-based imputation approach that leverages flanking diploid region information. Results: We identified numerous mCA, predominantly in individuals without cancer. Simulations showed effective classification in larger homozygosity regions (>10 Mb), guiding our methodological focus on detecting shorter high-MCF regions. Not surprisingly, extremely high MCFs (0.99-1) presented challenges in accurate identification. Conclusion and Future Directions: To improve our mCA results description, we will thoroughly characterize and study their association with cancer phenotypes and environmental exposures. We are in the process of genotyping the entire cohort, which consists of over 25,000 participants. To date, our cohort includes 909 cancer cases, of which 262 are hematological malignancies. We sought to design a unique method that differentiates high-MCF cn-LOH from observed ROH, improving current mCA discovery. Our focus is on small regions as they provide limited information to infer event types. Our next step is to characterize and validate our results, especially in pathologically normal samples, as a way of identifying potential biomarkers of interest. Citation Format: Jessica Valdebenito, Justin Wong, Dahwei Chang, Henry Gomez, Kevin T Nead, Yasminka Jakubek, Paul Scheet. Mosaic chromosomal alterations in a prospective cohort of Mexican Americans for cancer risk and genetic insights [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4849.

oncology
De novo detection of somatic variants in high-quality long-read single-cell RNA sequencing data

Arthur Dondi,Nico Borgsmüller,Pedro F. Ferreira,Brian J. Haas,Francis Jacob,Viola Heinzelmann-Schwarz,Tumor Profiler Consortium,Niko Beerenwinkel

DOI: https://doi.org/10.1101/2024.03.06.583775

2024-11-05

Abstract:In cancer, genetic and transcriptomic variations generate clonal heterogeneity, leading to treatment resistance. Long-read single-cell RNA sequencing (LR scRNA-seq) has the potential to detect genetic and transcriptomic variations simultaneously. Here, we present LongSom, a computational workflow leveraging high-quality LR scRNA-seq data to call de novo somatic single-nucleotide variants (SNVs), including in mitochondria (mtSNVs), copy-number alterations (CNAs), and gene fusions, to reconstruct the tumor clonal heterogeneity. Before somatic variants calling, LongSom re-annotates marker gene based cell types using cell mutational profiles. LongSom distinguishes somatic SNVs from noise and germline polymorphisms by applying an extensive set of hard filters and statistical tests. Applying LongSom to human ovarian cancer samples, we detected clinically relevant somatic SNVs that were validated against matched DNA samples. Leveraging somatic SNVs and fusions, LongSom found subclones with different predicted treatment outcomes. In summary, LongSom enables de novo variant detection without the need for normal samples, facilitating the study of cancer evolution, clonal heterogeneity, and treatment resistance.

Cancer Biology

Comparison of the bioavailability of aminophylline in a conventional base and in a continous-release base.

MosaicHunter: Accurate Detection of Postzygotic Single-Nucleotide Mosaicism Through Next-Generation Sequencing of Unpaired, Trio, and Paired Samples

DeepMosaic: Control-independent mosaic single nucleotide variant detection using deep convolutional neural networks

Control-independent mosaic single nucleotide variant detection with DeepMosaic

A robust benchmark for detecting low-frequency variants in the HG002 Genome In A Bottle NIST reference material.

Comprehensive identification of somatic nucleotide variants in human brain tissue

Detection of Mosaic Absence of Heterozygosity (AOH) Using Low-Pass Whole Genome Sequencing in Prenatal Diagnosis: A Preliminary Report

Detecting Somatic Mutations Without Matched Normal Samples Using Long Reads

Genome-wide detection of somatic mosaicism at short tandem repeats

Mitosomatic: a Tool for Accurate Identification of Mitochondrial DNA Somatic Mutations Without Paired Controls

Resolving the chromatin impact of mosaic variants with targeted Fiber-seq

Postzygotic Single-Nucleotide Mosaicisms in Whole-Genome Sequences of Clinically Unremarkable Individuals.

mosaicMPI: a framework for modular data integration across cohorts and -omics modalities

Robust identification of extrachromosomal DNA and genetic variants using multiple genetic abnormality sequencing (MGA-Seq)

High efficiency error suppression for accurate detection of low-frequency variants

Detection of mosaic and population-level structural variants with Sniffles2

On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients

Image-based DNA Sequencing Encoding for Detecting Low-Mosaicism Somatic Mobile Element Insertions

MosaicBase: A Knowledgebase of Postzygotic Mosaic Variants in Noncancer Diseases and Asymptomatic Human Individuals

Abstract 4849: Mosaic chromosomal alterations in a prospective cohort of Mexican Americans for cancer risk and genetic insights

De novo detection of somatic variants in high-quality long-read single-cell RNA sequencing data